Skip to content

Asthma and Obesity: Pilot Study

Obesity and Asthma: Unveiling Metabolic and Behavioral Pathways

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04113746
Enrollment
27
Registered
2019-10-03
Start date
2019-10-03
Completion date
2021-08-30
Last updated
2022-11-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma, Obesity

Keywords

Asthma, Obesity, Self-management behaviors

Brief summary

Develop and pilot test four theory-based educational modules that integrate counseling for asthma and obesity to promote greater physical activity among people with asthma.

Detailed description

Of the 400 obese and non-obese adult asthmatics in New York City and Denver during the 18-month observational phase of this study, the study team will randomize 80 participants (40 in NYC and 40 in Denver) into a 4-week group session pilot study focused on beliefs and behaviors associated with asthma and obesity self-management behaviors (SMB). Eligibility will be determined based on Asthma Control Questionnaire (ACQ) score and body mass index (BMI) at their 12-month visit. Participants will be randomized into an intervention or an active control arm after completing their 18-month visit. Participants will be consented into the pilot study during or after their 18-month visit. Participants will be put into groups of 7-10 for the pilot. Once formed, groups will have four 1-hour weekly visits. A person will be allowed to make up one missed session. The make-up session will be conducted on the phone or in-person depending on scheduling availability of both participant and care coach. Participants will be given accelerometers at sessions 1 and 4 that they will be asked to wear for seven days and return along with an activity diary. A follow-up survey will be administered about 30 days after the last pilot session in order to reassess the patient's asthma, obesity, exercise and medication beliefs and their adherence to asthma SMB. At the time of the follow-up survey, participants will also be given accelerometers that they will be asked to wear for seven days and return along with an activity diary.

Interventions

BEHAVIORALBetter asthma self-management and incorporation of physical activity

Participants in the asthma and exercise lifestyle change arm will participate in 4 sessions focused on behavioral change and goal-setting education to teach them how to better incorporate exercise into their daily lives and better manage their asthma. Following sessions 1 and 4, these participants will use the accelerometer to track activity, but will be blinded to the data.

General asthma education, but no discussion of the role of exercise and other lifestyle habits in asthma self-management. Following sessions 1 and 4, these participants will use the accelerometer to track activity, but will be blinded to the data.

Sponsors

University of Colorado, Denver
CollaboratorOTHER
National Heart, Lung, and Blood Institute (NHLBI)
CollaboratorNIH
Icahn School of Medicine at Mount Sinai
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE (Outcomes Assessor)

Masking description

The Research Coordinator who is administering the follow-up survey will be masked

Eligibility

Sex/Gender
ALL
Age
21 Years to 64 Years
Healthy volunteers
No

Inclusion criteria

* 21-64 years of age * BMI ≥ 30 * Asthma diagnosis made by a health care provider * Poor Asthma Control (ACQ score ≥ 0.75) * English speaking

Exclusion criteria

* BMI \< 30 * Good asthma control (ACQ score \<0.75) * Diagnosis of dementia * Diagnosis of chronic obstructive pulmonary disease (COPD) or other chronic respiratory illness * Smoking history of ≥15 pack-years owing to possible undiagnosed COPD

Design outcomes

Primary

MeasureTime frameDescription
Beliefs About Illness Perception Questionnaire (BIPQ)At 30 days Post-pilot follow-up visit, up to 2 monthsBIPQ includes 5 cognitive domains (Identity, Cause, Timeline, Consequences, and Cure-Control) designed to rapidly assess the cognitive and emotional representations of illness. Each item in each domain is scored on a 0 (none) to 10 (extreme). Full scale from 0-80, where higher score reflects a more threatening view of the illness.

Secondary

MeasureTime frameDescription
Physical Activity - Step Counts Per DayWeek 2, Week 4, and at 30 days Post-pilot follow-up visitPhysical activity monitoring using accelerometer and accompanying activity diary for self-report of wear. The accelerometer will measure step counts using previously determined cut-points. Based on accepted methodology, 3 or more out of the 7 days with 10 or more hours of wear time will be considered a valid measure of usual activity.
Time in Physical ActivityWeek 2, Week 4, and at 30 days Post-pilot follow-up visitPhysical activity monitoring using accelerometer and accompanying activity diary for self-report of wear. The accelerometer measured time spent in different intensities of activity using previously determined cut-points. Based on accepted methodology, 3 or more out of the 7 days with 10 or more hours of wear time was considered a valid measure of usual activity.
Medication Adherence Rating Scale (MARS)At 30 days Post-pilot follow-up visit, up to 2 monthsMARS is a self-reported questionnaire with the total score range from 0-10 with a higher score indicating better adherence.
Asthma Quality of Life Questionnaire (AQLQ)at 30 days post-pilot follow-up visit, up to 2 monthsAsthma Quality of Life Questionnaire (AQLQ) - self-reported asthma-related quality of life validated survey used to assess asthma-related quality of life at 30 days post-pilot follow-up visit. Total Score from 1-7, with higher score indicating better quality of life.
Beliefs About Medications Questionnaire (BMQ) - Necessity and Concerns Subscaleat 30 days post pilot follow-up visit, up to 2 monthsBeliefs about Medications Questionnaire (BMQ) - Necessity and Concerns The BMQ comprises two separate two five-item sub-scales (Necessity and Concerns) and assesses respondents' beliefs about prescribed medicines that they are currently using for specific conditions, for e.g. asthma. It assesses patients' beliefs about the necessity of prescribed medication for controlling their disease and their concerns about potential adverse consequences of taking it. Respondents indicate their degree of agreement with each statement on a five-point Likert scale, ranging from 1 - strongly disagree to 5 - strongly agree. Each subscale is scored from 5 -25. Scores obtained for individual items within both scales are summed. Thus, total scores for the Necessity and Concerns Scales range from 10-50. Higher scores indicate stronger beliefs in necessity or more concerns.
Asthma Control Questionnaire (ACQ)at 30 days Post-pilot follow-up visit, up to 2 monthsAsthma Control Questionnaire (ACQ) - self-reported asthma control validated survey, with a total score range from 0-6, with a higher score indicating severely uncontrolled asthma, used to assess current asthma control at 30 days post-pilot follow up visit.

Countries

United States

Participant flow

Recruitment details

Recruitment began in May 2019 with enrollment from Oct 2019-April 2021 at Icahn School of Medicine at Mount Sinai and University of Colorado, Denver)

Participants by arm

ArmCount
Asthma and Exercise Lifestyle Change
Participants receive asthma and lifestyle change education related to exercise Participants in the asthma and exercise lifestyle change arm participated in 4 sessions focused on behavioral change and goal-setting education to teach them how to better incorporate exercise into their daily lives and better manage their asthma. Following sessions 1 and 4, these participants used the accelerometer to track activity, but was blinded to the data.
13
Asthma Education
No lifestyle change education Asthma Education: General asthma education, but no discussion of the role of exercise and other lifestyle habits in asthma self-management. Following sessions 1 and 4, these participants used the accelerometer to track activity, but was blinded to the data.
14
Total27

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyLost to Follow-up44

Baseline characteristics

CharacteristicAsthma and Exercise Lifestyle ChangeAsthma EducationTotal
Age, Continuous47.2 years
STANDARD_DEVIATION 10.7
48.7 years
STANDARD_DEVIATION 14.8
48 years
STANDARD_DEVIATION 12.7
Body Mass Index (BMI)37 kg/m^2
STANDARD_DEVIATION 6.5
39.6 kg/m^2
STANDARD_DEVIATION 8.7
38.2 kg/m^2
STANDARD_DEVIATION 7.5
Education
Any College
5 Participants4 Participants9 Participants
Education
Any High School
0 Participants2 Participants2 Participants
Education
College Graduate
3 Participants5 Participants8 Participants
Education
Elementary
0 Participants1 Participants1 Participants
Education
Higher Degree
0 Participants1 Participants1 Participants
Education
High School Graduate
5 Participants1 Participants6 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
4 Participants5 Participants9 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
7 Participants8 Participants15 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
2 Participants1 Participants3 Participants
Insurance
Medicaid
7 Participants6 Participants13 Participants
Insurance
Medicare
1 Participants0 Participants1 Participants
Insurance
Medicare and Medicaid
0 Participants1 Participants1 Participants
Insurance
Missing
3 Participants4 Participants7 Participants
Insurance
Private
2 Participants3 Participants5 Participants
Language
English
12 Participants12 Participants24 Participants
Language
Spanish
1 Participants2 Participants3 Participants
Marital Status
Married
3 Participants7 Participants10 Participants
Marital Status
Unmarried
10 Participants7 Participants17 Participants
Monthly Income
Less than $3000
9 Participants10 Participants19 Participants
Monthly Income
Missing/refused
2 Participants2 Participants4 Participants
Monthly Income
More than $3000
2 Participants2 Participants4 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Black or African American
3 Participants5 Participants8 Participants
Race (NIH/OMB)
More than one race
4 Participants5 Participants9 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
2 Participants1 Participants3 Participants
Race (NIH/OMB)
White
4 Participants3 Participants7 Participants
Sex: Female, Male
Female
12 Participants13 Participants25 Participants
Sex: Female, Male
Male
1 Participants1 Participants2 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 130 / 14
other
Total, other adverse events
0 / 130 / 14
serious
Total, serious adverse events
0 / 130 / 14

Outcome results

Primary

Beliefs About Illness Perception Questionnaire (BIPQ)

BIPQ includes 5 cognitive domains (Identity, Cause, Timeline, Consequences, and Cure-Control) designed to rapidly assess the cognitive and emotional representations of illness. Each item in each domain is scored on a 0 (none) to 10 (extreme). Full scale from 0-80, where higher score reflects a more threatening view of the illness.

Time frame: At 30 days Post-pilot follow-up visit, up to 2 months

ArmMeasureValue (MEAN)Dispersion
Asthma and Exercise Lifestyle ChangeBeliefs About Illness Perception Questionnaire (BIPQ)42.6 score on a scaleStandard Deviation 11.4
Asthma EducationBeliefs About Illness Perception Questionnaire (BIPQ)36.2 score on a scaleStandard Deviation 8.2
Secondary

Asthma Control Questionnaire (ACQ)

Asthma Control Questionnaire (ACQ) - self-reported asthma control validated survey, with a total score range from 0-6, with a higher score indicating severely uncontrolled asthma, used to assess current asthma control at 30 days post-pilot follow up visit.

Time frame: at 30 days Post-pilot follow-up visit, up to 2 months

ArmMeasureValue (MEAN)Dispersion
Asthma and Exercise Lifestyle ChangeAsthma Control Questionnaire (ACQ)1.6 score on a scaleStandard Deviation 1
Asthma EducationAsthma Control Questionnaire (ACQ)1.3 score on a scaleStandard Deviation 0.9
Secondary

Asthma Quality of Life Questionnaire (AQLQ)

Asthma Quality of Life Questionnaire (AQLQ) - self-reported asthma-related quality of life validated survey used to assess asthma-related quality of life at 30 days post-pilot follow-up visit. Total Score from 1-7, with higher score indicating better quality of life.

Time frame: at 30 days post-pilot follow-up visit, up to 2 months

ArmMeasureValue (MEAN)Dispersion
Asthma and Exercise Lifestyle ChangeAsthma Quality of Life Questionnaire (AQLQ)4.9 score on a scaleStandard Deviation 0.8
Asthma EducationAsthma Quality of Life Questionnaire (AQLQ)5.0 score on a scaleStandard Deviation 0.6
Secondary

Beliefs About Medications Questionnaire (BMQ) - Necessity and Concerns Subscale

Beliefs about Medications Questionnaire (BMQ) - Necessity and Concerns The BMQ comprises two separate two five-item sub-scales (Necessity and Concerns) and assesses respondents' beliefs about prescribed medicines that they are currently using for specific conditions, for e.g. asthma. It assesses patients' beliefs about the necessity of prescribed medication for controlling their disease and their concerns about potential adverse consequences of taking it. Respondents indicate their degree of agreement with each statement on a five-point Likert scale, ranging from 1 - strongly disagree to 5 - strongly agree. Each subscale is scored from 5 -25. Scores obtained for individual items within both scales are summed. Thus, total scores for the Necessity and Concerns Scales range from 10-50. Higher scores indicate stronger beliefs in necessity or more concerns.

Time frame: at 30 days post pilot follow-up visit, up to 2 months

ArmMeasureGroupValue (MEAN)Dispersion
Asthma and Exercise Lifestyle ChangeBeliefs About Medications Questionnaire (BMQ) - Necessity and Concerns SubscaleNecessity Subscale15 score on a scaleStandard Deviation 3.6
Asthma and Exercise Lifestyle ChangeBeliefs About Medications Questionnaire (BMQ) - Necessity and Concerns SubscaleConcerns Subscale8.4 score on a scaleStandard Deviation 1
Asthma EducationBeliefs About Medications Questionnaire (BMQ) - Necessity and Concerns SubscaleNecessity Subscale16.4 score on a scaleStandard Deviation 5
Asthma EducationBeliefs About Medications Questionnaire (BMQ) - Necessity and Concerns SubscaleConcerns Subscale8.4 score on a scaleStandard Deviation 2.7
Secondary

Medication Adherence Rating Scale (MARS)

MARS is a self-reported questionnaire with the total score range from 0-10 with a higher score indicating better adherence.

Time frame: At 30 days Post-pilot follow-up visit, up to 2 months

Population: Data only obtained from participants on a controller medication.

ArmMeasureValue (MEAN)Dispersion
Asthma and Exercise Lifestyle ChangeMedication Adherence Rating Scale (MARS)4.7 score on a scaleStandard Deviation 0.5
Asthma EducationMedication Adherence Rating Scale (MARS)4.7 score on a scaleStandard Deviation 0.5
Secondary

Physical Activity - Step Counts Per Day

Physical activity monitoring using accelerometer and accompanying activity diary for self-report of wear. The accelerometer will measure step counts using previously determined cut-points. Based on accepted methodology, 3 or more out of the 7 days with 10 or more hours of wear time will be considered a valid measure of usual activity.

Time frame: Week 2, Week 4, and at 30 days Post-pilot follow-up visit

Population: Data for participants with accelerometers with valid analyzable data.

ArmMeasureGroupValue (MEAN)Dispersion
Asthma and Exercise Lifestyle ChangePhysical Activity - Step Counts Per DayWeek 212253.3 steps/dayStandard Deviation 0
Asthma and Exercise Lifestyle ChangePhysical Activity - Step Counts Per DayWeek 413730.2 steps/dayStandard Deviation 0
Asthma and Exercise Lifestyle ChangePhysical Activity - Step Counts Per Dayat 30 days post pilot follow-up visit2667.9 steps/dayStandard Deviation 375.4
Asthma EducationPhysical Activity - Step Counts Per DayWeek 22499.7 steps/dayStandard Deviation 1514.9
Asthma EducationPhysical Activity - Step Counts Per DayWeek 42123.9 steps/dayStandard Deviation 1751
Asthma EducationPhysical Activity - Step Counts Per Dayat 30 days post pilot follow-up visit3715.1 steps/dayStandard Deviation 3041.5
Secondary

Time in Physical Activity

Physical activity monitoring using accelerometer and accompanying activity diary for self-report of wear. The accelerometer measured time spent in different intensities of activity using previously determined cut-points. Based on accepted methodology, 3 or more out of the 7 days with 10 or more hours of wear time was considered a valid measure of usual activity.

Time frame: Week 2, Week 4, and at 30 days Post-pilot follow-up visit

Population: Data for participants with accelerometers with valid analyzable data.

ArmMeasureGroupValue (MEAN)Dispersion
Asthma and Exercise Lifestyle ChangeTime in Physical ActivityWeek 274.5 minutes/dayStandard Deviation 0
Asthma and Exercise Lifestyle ChangeTime in Physical ActivityWeek 491.5 minutes/dayStandard Deviation 0
Asthma and Exercise Lifestyle ChangeTime in Physical Activityat 30 days post pilot follow-up visit9.9 minutes/dayStandard Deviation 6.8
Asthma EducationTime in Physical ActivityWeek 28.6 minutes/dayStandard Deviation 7
Asthma EducationTime in Physical ActivityWeek 410.3 minutes/dayStandard Deviation 8.3
Asthma EducationTime in Physical Activityat 30 days post pilot follow-up visit7.8 minutes/dayStandard Deviation 9.2

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026